Project 2 – Life Sciences

Fundraising/commercialisation strategy

Deep tech/life science – Fundraising

From technical capability to fundable business model

A deep-tech venture with strong IP and technical validation faced challenges in articulating its commercial pathway. The core issue was not the technology itself, but the absence of a clearly defined route to market.

The engagement focused on:
– Prioritising high-value applications with identifiable buyers
– Mapping customer adoption pathways and constraints
– Designing a commercial model aligned with value creation
– Defining capital milestones tied to market validation

This repositioned the company from a technology-led narrative to a commercially legible investment opportunity, enabling investors to assess both risk and scalability.